Induction of apoptosis by phenylisocyanate derivative of quercetin: Involvement of heat shock protein

Anti-Cancer Drugs

Volumn 18, Issue 10, 2007, Pages 1165-1171

  Ye, Bin ^a,c   Yang, Jin Liang ^a   Chen, Li Juan ^a   Wu, Xian Xue ^b,d   Yang, Han Shuo ^a   Zhao, Ju Mei ^a   Yuan, Zhi Ping ^a   Li, Jiong ^a   Wen, Yan Jun ^a   Mao, Yong Qiu ^a   Lei, Song ^a   Kan, Bing ^a   Fan, Lin Yu ^a   Yao, Wen Xiu ^a   Wang, Rui ^a   Wang, Guo Qing ^a   Du, Xiao Bo ^a   Liu, Huan Yi ^a   Wu, Hong Bing ^a   Xu, Jian Rong ^a   Li, Hong Xia ^a   Zhang, Wei ^a   Zhao, Xia ^a   Wei, Yu Quan ^a   Cheng, Li ^a,b   more..

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Third People's Hospital of Chengdu   (China)

^d YUXI NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Heat shock protein 70; Phenylisocyanate of quercetin; Quercetin; Structure modification

Indexed keywords

HEAT SHOCK PROTEIN 70; PHENYL ISOCYANATE; PROPIDIUM IODIDE; QUERCETIN; QUERCETIN DERIVATIVE;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MORPHOLOGY; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; STAINING;

ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HSP70 HEAT-SHOCK PROTEINS; HUMANS; QUERCETIN; TIME FACTORS;

EID: 34748817994     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e3280145274     Document Type: Article

References (30)

1. Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000; 63:1035-1042.
2. Wu XX, Cheng L, Xiang D, Wei YQ. Syntheses of carbamate derivatives of quercetin by reaction with amino acid ester isocyanates. Lett Org Chem 2005; 2:535-538.
3. Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A, et al. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res 1994; 54:4952-4957.
4. Scambia G, Ranelletti FO, Panici PB, Piantelli M, De Vincenzo R, Ferrandina G, et al. Quercetin induces type-II estrogen-binding sites in estrogen-receptor negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast cancer. Int J Cancer 1993; 54:462-466.
5. Hosokawa N, Hirayoshi K, Kudo H, Takechi H, Aoike A, Kawai K, et al. Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol Cell Biol 1992; 12:3490-3498.
6. Hosokawa N, Hirayoshi K, Nakai A, Hosokawa Y, Marui N, Yoshida M, et al. Flavonoids inhibit the expression of heat shock proteins. Cell Struct Funct 1990; 15:393-401.
7. Scambia G, Ranelletti FO, Benedetti Panici P, Piantelli M, Bonanno G, De Vincenzo R, et al. Inhibitory effect of quercetin on primary ovarian and endometrial cancer and synergistic activity with cisdiamminedichloroplatinum(α). Gynecol Oncol 1992; 45:13-19.
8. Verma A, Johnsons JA, Gould MN, Tanner MA. Inhibition of 7,12-dimethylbenz(a)anthracene and N-nitrosomethylurea induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 1988; 48:5754-5758.
9. 1 in these cells. Blood 1995; 85:3654-3661.
10. Ranelletti FO, Ricci R, Larocca LM, Maggiano N, Capelli A, Scambia G, et al. Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colomrectal tumors. Int J Cancer 1992; 50:486-492.
11. + chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-α, TNF, and quercetin): its application to autologous bone marrow transplantation for CMI. Exp Hematol 1995; 23:444-452.
12. Prajda N, Singhal RL,Yeh YA, Olah E, Look KY, Weber G. Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin. Life Sci 1995; 56:1587-1593.
13. Avila MA, Velasco JA, Cansado J, Notario V. Quercetin mediates the down-regulation of mutant p53 in the Human breast cancer cell lines MDA-MB468. Cancer Res 1994; 54:2424-2428.
14. 2 lymphoma cells. Proc Soc Exp Boil Med 1995; 209:257-269.
15. Wei YQ, Zhao X, Kariya Y, Teshigawara K, Uchida A. Inhibition of proliferation and induction of apoptosis by abrogation of heat-shock protein (HSP) 70 expression in tumor cells. Cancer Immunol Immunother 1995; 40:73-78.
16. Malherbe S, Crepin M, Legrand C, Wei MX. Cytostatic and pro-apoptotic effects of a novel phenylacetate-dextran derivative (NaPaC) on breast cancer cells in interactions with endothelial cells. Anticancer Drugs 2004; 15:975-981.
17. Li Q, Wei YQ, Wen YJ, Zhao X, Tian L, Yang L, et al. Induction of apoptosis and tumor regression by vesicular stomatitis virus in the presence of gemcitaibne in lung cancer. Int J Cancer 2004; 112:143-149.
18. Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 1993; 53:3186-3192.
19. Barry MA, Reynolds JE, Eastman A. Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res 1993; 53:2349-2357.
20. Wu Y, Yang L, Hu B, Liu JY, Su JM, Luo Y, et al. Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine. Anticancer Drugs 2005; 16:551-557.
21. Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 1995; 33:1061-1080.
22. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362:847-849.
23. Walton MI, Whysong D, O'Connor PM, Hockenbery D, Korsmeyer SJ, Kohn KW. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 1993; 53:1853-1861.
24. Forbes IJ, Zalewski PD, Giannakis C, Cowled PA. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp Cell Res 1992; 198:367-372.
25. Evans DL, Dive C. Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res 1993; 53:2133-2139.
26. Eastman A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 1990; 2:275-280.
27. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139:271-279.
28. Eastman A, Rigas JR. Modulation of apoptosis signaling pathways and cell cycle regulation. Semin Oncol 1999; 26:7-16.
29. Nguyen JT, Wells JA. Direct activation of the apoptosis machinery as a mechanism to target cancer cells. Proc Natl Acad Sci USA 2003; 100:7533-7538.
30. Jaattela M, Wissing D. Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection. J Exp Med 1993; 177:231-236.